Evidence map›Paper›PMID 40945658›Full record

ArticleEndocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists2026

Primary Aldosteronism Surgery Outcomes Under Current Blood Pressure Guidelines.

Kidmealem Zekarias, Jacob Kohlenberg, Sayeed Ikramuddin

Abstract read
In one paragraph

Article in Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kidmealem ZekariasDivision of Diabetes, Endocrinology and Metabolism, University of Minnesota, Minneapolis, Minnesota. Electronic address: kzekaria@umn.edu.
Jacob KohlenbergDivision of Diabetes, Endocrinology and Metabolism, University of Minnesota, Minneapolis, Minnesota.
Sayeed IkramuddinDepartment of Surgery, University of Minnesota, Minneapolis, Minnesota.

Funding

VNS Modulation of the Central Autonomic Network and its Effects on ANSU54AT012307 · NCCIH · UNIVERSITY OF MINNESOTA · PI NAHAS, ZIAD · 2022 to 2024
$21.6M
Diabetes-Docs: Physician-Scientist Career Development Program (DiabDocs)K12DK133995 · NIDDK · STANFORD UNIVERSITY · PI LINDA A DIMEGLIO, David Matthew Maahs · 2022 to 2026
$16.0M
Vertical Sleeve Gastrectomy for Treatment of NASH: a pilot randomized controlR01DK128325 · NIDDK · UNIVERSITY OF MINNESOTA · PI HAMEED, BILAL, IKRAMUDDIN, SAYEED · 2021 to 2023
$947k
M-STEPPR25HL173964 · NHLBI · UNIVERSITY OF MINNESOTA · PI SAYEED IKRAMUDDIN, DAVID R JACOBS · 2024 to 2026
$474k
NCCIH NIH HHS U54 AT012307NHLBI NIH HHS R25 HL173964NIDDK NIH HHS K12 DK133995NIDDK NIH HHS R01 DK128325
6 · The paper itself

Abstract

objectiveHistorical studies report complete clinical success rates of 37% following adrenalectomy for primary aldosteronism (PA), based on the former blood pressure (BP) threshold of <140/90 mmHg. This study evaluated outcomes using the current guideline BP threshold of <130/80 mmHg.

methodsWe conducted a retrospective cohort study using the Epic COSMOS database of 1320 adults who underwent adrenalectomy for PA (2013-2024). Inclusion criteria included preoperative plasma aldosterone measurement and ambulatory BP measurements within 6 months and 6-18 months post-adrenalectomy. After excluding patients who had pre-adrenalectomy BP < 130/80 mmHg without antihypertensive therapy, 1079 patients were analyzed.

resultsComplete clinical success (BP < 130/80 mmHg without medications post-adrenalectomy) occurred in 16.5% (178/1079; 95% CI: 14.3-18.7). Partial clinical success (improved BP control and/or reduced medications post-adrenalectomy) was achieved by 73.5% (793/1079; 95% CI: 70.9-76.1). Absent clinical success occurred in 10% (108/1079; 95% CI: 8.2-11.8). The combined rate of complete and partial clinical success was 90% (971/1079; 95% CI: 88.2-91.8). Multivariable logistic regression identified significant predictors of absence of complete clinical success: more preoperative antihypertensive medications (P < .001), higher social vulnerability (P = .02), and higher baseline systolic (P = .01) and diastolic BP (P = .003). Age, gender, race, body mass index, stroke history, sleep apnea, pre-adrenalectomy serum potassium, and estimated glomerular filtration rate were not significantly associated with outcomes.

conclusionWhen applying current BP guidelines, 90% of patients achieve complete or partial clinical success after adrenalectomy for PA, demonstrating meaningful clinical outcomes. However, complete clinical success occurs in fewer patients (16.5%) than previously reported under traditional thresholds.

Indexed as

AdrenalectomyBlood PressureHyperaldosteronismHypertensionAdultAgedAntihypertensive AgentsFemaleHumansMaleMiddle AgedPractice Guidelines as TopicRetrospective StudiesTreatment OutcomeAntihypertensive Agentsadrenalectomyblood pressureclinical outcomesprimary aldosteronismsurgical outcomes

Identifiers

PMID40945658
PMCPMC13102164

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.